← Eichor
Study identifier: NCT07170748 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)

Condition: Multiplex Testing of HIV, HBV, HCV and Syphilis · HIV · HBV  ·  Sponsor: MagIA Diagnostics

PhaseN/A
Planned participants2950
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Performance study to evaluate the clinical performance of the In-Vitro Diagnostics Medical Device MagIA H3S (a Multiplex Point-of-Care test for the combined detection of Human Immunodeficiency Virus (HIV), Hepatitis B and C and Syphilis) from serum, plasma samples collected prospectively or retrospectively in Ivory Coast and Kenya.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (2)

Centre de Diagnostic et de Recherche sur le SIDA et les autres Maladies Infectieuses - CHU TreichvilleAbidjan, Côte d’IvoireRecruiting
Kenya Medical Research Institute (KEMRI)Nairobi, KenyaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07170748